Pluri Inc. — Director's Dealing 2016

Feb 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2016-02-15

Reporting Person: SHORRER DORON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-15	Common Stock	P	12346	$0.8074	Acquired	582554	Indirect

Footnotes

F1: The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for a per share purchase price of NIS 3.14, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.889 per U.S. dollar.